Right-first-time: raising the bar at NHS Wakefield.
“If you don’t get it right first time, money is wasted by inefficiencies.” Dr Philip Earnshaw, Wakefield GP, CCG Chair:… Read More
This is my archive
Health Tech 2017: a case for greater connection, featuring Forte Medical
Leading international law firm Nabarro today issued a report on UK Med Tech. The document features interviews with industry opinion formers drawn from the Association… Read More
Philip Kennedy appointed Non-Executive Director at Forte Medical
Forte Medical, the designer and manufacturer of innovative medical devices to improve specimen collection, is pleased to announce the appointment of Philip Kennedy as a… Read More
Managing Innovation in Healthcare
In his new book “Managing Innovation in Healthcare”, Professor James Barlow has written about Forte Medical’s journey to achieve adoption of its Peezy Midstream system… Read More
Diagnostic innovation: making midstream mainstream
Forte Medical’s MedTech is low tech … and that’s the point at which interest wanes, for people want the intangible techie stuff, the next… Read More
Pitch@Palace: what’s that all about, then?
“Why don’t you go for Pitch@Palace?” asked a new business contact. Why indeed! I had never heard of it and frankly, what could The Palace… Read More
ABHI Mission to Texas: we have lift-off
“You will get out of the ABHI what you put in,” said a friendly counterpart from the Urology world, to whom I had been sent… Read More
Reducing contamination in urine samples
Professor Frank Chindgwundoh MBE talks to News-Medical.net about the issues around inaccurate urine screening and how repeat testing and repeat patient appointments can be… Read More
The Forte Medical Forum at the Royal Society of Medicine
We are proud to be part of Urology Awareness Month this September: “Clinical Innovation in Specimen Collection and Diagnostics” Royal Society of Medicine… Read More
NHS: brick walls to innovation and £30m savings
65m urine specimens are taken every year on the NHS … without a defined protocol. Mixed growth rates (unreliable specimens) vary from 1.4% to over… Read More
